For the year ending 2025-12-31, CG had $707,100K increase in cash & cash equivalents over the period. -$3,374,900K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income (loss) | 944,700 |
| Depreciation and amortization | 192,100 |
| Equity-based compensation | 374,700 |
| Non-cash performance allocations and incentive fees, net | 278,500 |
| Non-cash principal investment (income) loss | -93,800 |
| Other non-cash amounts | -33,900 |
| Realized/unrealized (gain) loss on investments of consolidated funds | 16,500 |
| Realized/unrealized (gain) loss from loans payable of consolidated funds | 101,500 |
| Purchases of investments by consolidated funds | 11,700,400 |
| Proceeds from sales and settlements of investments by consolidated funds | 6,413,400 |
| Non-cash interest income, net | 29,200 |
| Change in cash and cash equivalents held at consolidated funds | -119,300 |
| Change in other receivables held at consolidated funds | -50,200 |
| Change in other liabilities held at consolidated funds | 170,700 |
| Purchases of investments | 403,600 |
| Proceeds from the sale of investments | 832,900 |
| Payments of contingent consideration | 2,700 |
| Changes in deferred taxes, net | 29,800 |
| Change in due from affiliates and other receivables | -44,700 |
| Change in deposits and other | 41,000 |
| Change in accounts payable, accrued expenses and other liabilities | 149,700 |
| Change in accrued compensation and benefits | 95,100 |
| Change in due to affiliates | 27,000 |
| Change in lease right-of-use assets and lease liabilities | -10,400 |
| Change in deferred revenue | -16,500 |
| Net cash provided by (used in) operating activities | -3,275,500 |
| Purchases of corporate treasury investments | 0 |
| Proceeds from corporate treasury investments | 0 |
| Purchases of fixed assets, net | 99,400 |
| Net cash used in investing activities | -99,400 |
| Borrowings under credit facilities | 0 |
| Repayments under credit facilities | 0 |
| Issuance of 5.050 senior notes due 2035, net of financing costs | 794,900 |
| Proceeds from clo borrowings, net of financing costs | 90,000 |
| Payments on clo borrowings | 56,500 |
| Net borrowings on loans payable of consolidated funds | 4,012,500 |
| Dividends to common stockholders | 505,100 |
| Payment of deferred consideration for carlyle holdings units | 0 |
| Contributions from non-controlling interest holders | 711,700 |
| Distributions to non-controlling interest holders | 340,800 |
| Common shares repurchased and net share settlement of equity awards | 686,500 |
| Change in due to/from affiliates financing activities | 29,800 |
| Net cash provided by (used in) financing activities | 3,990,400 |
| Effect of foreign exchange rate changes | 91,600 |
| Increase (decrease) in cash, cash equivalents and restricted cash | 707,100 |
| Cash, cash equivalents and restricted cash, beginning of period | 1,266,500 |
| Cash, cash equivalents and restricted cash, end of period | 1,973,600 |
Carlyle Group Inc. (CG)
Carlyle Group Inc. (CG)